Induced Pluripotent Stem Cells Meet Genome Editing

It is extremely rare for a single experiment to be so impactful and timely that it shapes and forecasts the experiments of the next decade. Here, we review how two such experiments - the generation of human induced pluripotent stem cells (iPSCs) and the development of CRISPR/Cas9 technology - have f...

Full description

Bibliographic Details
Main Authors: Hockemeyer, Dirk, Jaenisch, Rudolf
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Published: Elsevier 2018
Online Access:http://hdl.handle.net/1721.1/116609
_version_ 1826190605811712000
author Hockemeyer, Dirk
Jaenisch, Rudolf
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Hockemeyer, Dirk
Jaenisch, Rudolf
author_sort Hockemeyer, Dirk
collection MIT
description It is extremely rare for a single experiment to be so impactful and timely that it shapes and forecasts the experiments of the next decade. Here, we review how two such experiments - the generation of human induced pluripotent stem cells (iPSCs) and the development of CRISPR/Cas9 technology - have fundamentally reshaped our approach to biomedical research, stem cell biology, and human genetics. We will also highlight the previous knowledge that iPSC and CRISPR/Cas9 technologies were built on as this groundwork demonstrated the need for solutions and the benefits that these technologies provided and set the stage for their success.
first_indexed 2024-09-23T08:42:35Z
format Article
id mit-1721.1/116609
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T08:42:35Z
publishDate 2018
publisher Elsevier
record_format dspace
spelling mit-1721.1/1166092022-09-23T14:03:20Z Induced Pluripotent Stem Cells Meet Genome Editing Hockemeyer, Dirk Jaenisch, Rudolf Massachusetts Institute of Technology. Department of Biology Jaenisch, Rudolf It is extremely rare for a single experiment to be so impactful and timely that it shapes and forecasts the experiments of the next decade. Here, we review how two such experiments - the generation of human induced pluripotent stem cells (iPSCs) and the development of CRISPR/Cas9 technology - have fundamentally reshaped our approach to biomedical research, stem cell biology, and human genetics. We will also highlight the previous knowledge that iPSC and CRISPR/Cas9 technologies were built on as this groundwork demonstrated the need for solutions and the benefits that these technologies provided and set the stage for their success. National Institutes of Health (U.S.) (Grant 1R01NS088538-01) National Institutes of Health (U.S.) (Grant 2R01MH104610-15) 2018-06-26T14:20:10Z 2018-06-26T14:20:10Z 2016-05 2018-06-26T13:03:46Z Article http://purl.org/eprint/type/JournalArticle 1934-5909 http://hdl.handle.net/1721.1/116609 Hockemeyer, Dirk, and Rudolf Jaenisch. “Induced Pluripotent Stem Cells Meet Genome Editing.” Cell Stem Cell 18, 5 (May 2016): 573–586 © 2016 Elsevier Inc http://dx.doi.org/10.1016/J.STEM.2016.04.013 Cell Stem Cell Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Elsevier PMC
spellingShingle Hockemeyer, Dirk
Jaenisch, Rudolf
Induced Pluripotent Stem Cells Meet Genome Editing
title Induced Pluripotent Stem Cells Meet Genome Editing
title_full Induced Pluripotent Stem Cells Meet Genome Editing
title_fullStr Induced Pluripotent Stem Cells Meet Genome Editing
title_full_unstemmed Induced Pluripotent Stem Cells Meet Genome Editing
title_short Induced Pluripotent Stem Cells Meet Genome Editing
title_sort induced pluripotent stem cells meet genome editing
url http://hdl.handle.net/1721.1/116609
work_keys_str_mv AT hockemeyerdirk inducedpluripotentstemcellsmeetgenomeediting
AT jaenischrudolf inducedpluripotentstemcellsmeetgenomeediting